Evofem Biosciences, Inc. 8-K

What Happened
Evofem Biosciences, Inc. announced via Form 8‑K (filed January 12, 2026) that it has posted its current corporate slide presentation to the "Investors" section of its website (www.evofem.com). The filing is made as a Regulation FD disclosure and attaches the slide deck as Exhibit 99.1. The company stated it has no obligation to update, supplement or amend the posted materials.

Key Details

• Form 8‑K filed January 12, 2026 under Item 7.01 (Regulation FD Disclosure).
• Corporate slide presentation is attached as Exhibit 99.1 and was prepared as of January 12, 2026.
• Presentation is posted on Evofem’s investor website: www.evofem.com.
• The company expressly disclaims any obligation to update the presentation; the 8‑K does not report earnings, revenue, executive changes, mergers, or other transaction filings.

Why It Matters
This 8‑K gives investors and analysts official access to Evofem’s latest corporate overview and strategic messaging in a single, publicly available slide deck. Because the filing is a Regulation FD disclosure, the information was shared publicly to ensure fair disclosure to all market participants. Investors should review the slides for context on the company’s priorities and pipeline, but note the 8‑K itself does not contain new financial results or binding commitments.